Intrinsic Value

Is MPAL undervalued or overvalued?

See the intrinsic value estimate for Medpal AI PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MPAL Intrinsic Value
LOCKED
Unlock
Today vs. history

MPAL looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with MPAL’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor MPAL
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price 4.9
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MPAL

Fundamental Analysis

What Medpal AI Does

Health Care

Medpal AI PLC appears to build software that uses artificial intelligence to help people handle health-related tasks more easily. In plain terms, it is a healthcare software company, not a drug maker or hospital operator. Its value comes from turning medical information, reminders, and routine support into digital tools that patients and clinicians can use day to day.

Headquarters
United Kingdom UK
Employees
1
IPO date
Aug 26, 2025
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Medpal AI PLC

Efficiency

Earnings Waterfall
Medpal AI PLC

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one MPAL stock?

The intrinsic value for Medpal AI PLC (MPAL) under the Base Case is hidden GBX.

Is MPAL stock undervalued or overvalued?

Compared with the current market price of 4.9 GBX, the stock appears hidden.

Back to Top